Results 211 to 220 of about 40,011 (243)

Interferon gamma release assays for diagnosing active and latent tuberculosis

Expert Opinion on Medical Diagnostics, 2009
In view of the continuing global epidemic of tuberculosis (TB), adequate diagnosis is crucial for controlling this disease. Two commercial interferon gamma release assays (IGRA) have become available: the QuantiFERON-TB (QFT) and the T-SPOT.TB (TSPOT). They offer an important new tool for detecting both latent and active TB.
Steven Ft, Thijsen, Ailko Wj, Bossink
openaire   +2 more sources

Screening for Mycobacterium tuberculosis Using an Interferon-Gamma Release Assay

Journal of Public Health Management and Practice, 2012
The Centers for Disease Control and Prevention recommend analyzing characteristics of populations screened for Mycobacterium tuberculosis infection using interferon-gamma release assays (IGRAs).We characterized requests for IGRA analyses submitted to the first laboratory in Washington State that began to offer IGRAs as a tuberculosis screening test. In
Terri, Simpson, Joyce, Fox, Karen, Crouse, Kimberly, Field   +3 more
openaire   +2 more sources

[Research agenda of interferon-gamma release assays].

Kekkaku : [Tuberculosis], 2009
Recently, new diagnostic tests for tuberculosis infection that are more specific than tuberculin skin tests have been developed and have become commercially available. These tests determine interferon-gamma production after stimulation with M. tuberculosis-specific antigens, ESAT-6 and CFP-10, and are named Interferon-Gamma Release Assays (IGRA ...
Kazue, Higuchi, Nobuyuki, Harada
openaire   +1 more source

Interferon-gamma-release assay prevents unnecessary tuberculosis therapy.

The Israel Medical Association journal : IMAJ, 2015
The mass influx of immigrants from tuberculosis-endemic countries into Israel was followed by a considerable increase in the incidence of tuberculosis (TB). All contacts of active TB patients are obliged to be screened by tuberculin skin tests (TST) and, if found positive, prophylactic treatment is considered.To assess the utility of interferon-gamma ...
Vered, Schichter-Konfino, Katalin, Halasz, Galia, Grushko, Ayelet, Snir, Tharwat, Haj, Zahava, Vadasz, Aharon, Kessel, Israel, Potasman, Elias, Toubi   +8 more
openaire   +3 more sources

Interferon-gamma Release Assays

DMW - Deutsche Medizinische Wochenschrift, 2007
A Schablon, A Niehaus
openaire   +1 more source

Serial Interferon Gamma Release Assay in Latent Tuberculosis Infection

Laboratory medicine, 2009
The aim of this report is to present results of serial interferon-gamma (IFN-γ ) determination (QuantiFERON-TB Gold In-Tube assay) in a 57-year-old BCG-vaccinated female health care worker with a latent tuberculosis infection. Increased IFN-γ , IgA, and anti-thyroglobulin (anti-Tg) autoantibodies were recorded throughout a 13-month follow-up.
Zrinski Topić, Renata, Dodig, Slavica
openaire   +1 more source

Interferon-Gamma Release Assays

2022
openaire   +1 more source

Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

Journal of Pediatrics, 2021
Fernando Baquero, Begoña Santiago García, Ana Mendez-Echevarria   +2 more
exaly  

[Interferon-gamma release assay on suspicion of active tuberculosis?].

Ugeskrift for laeger, 2009
The purpose of this retrospective study was to outline the practical use and clinical value of the immunodiagnostic interferon-gamma release assay (IGRA) on suspicion of active Mycobacterium tuberculosis (TB) infection.A retrospective study of all patients (n=91) tested with IGRA (Quantiferon-TB-Gold, Celletis International, Australia) for M ...
Andrea, Browatzki, Christian Niels, Meyer   +1 more
openaire   +1 more source

Interferon-gamma Release Assays - Erwiderung

DMW - Deutsche Medizinische Wochenschrift, 2007
M Löbermann, E. C Reisinger, W Frank
openaire   +1 more source